Tests Catalogs

Alpha-1-Antitrypsin Phenotype

LAB4215

Collect

Serum separator tube or plain red.

Specimen Preparation

Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.3 mL)

Storage/Transport Temperature

Refrigerated.

Stability (from collection to initiation)

After separation from cells: Ambient: 1 week; Refrigerated: 3 months; Frozen: 3 months (avoid repeated freeze/thaw cycles)

Notes

Interpret with caution if the patient has been transfused within the previous 21 days.

Performed

Sun-Sat

Methodology

Qualitative Isoelectric Focusing/Immunoturbidimetry

Reported

2-4 days

Synonyms

  • A1A Phenotype
  • AAT Phenotype
  • Protease Inhibitor Typing
  • AAT Phenotyping
  • Protease Inhibitor Allo Typing
  • AAT deficiency
  • Antitrypsin
  • A1A Phenotyping
  • AAT Reflex
  • Antitrypsin, Phenotype
  • A1A reflex
  • Alpha 1 Antitrypsin
  • a-1-Antitrypsin, Phenotype
  • A1A genotyping/phenotyping reflex
  • Pi Typing

Additional Technical Information

Ordering Recommendations

Determine specific AAT protein variant(s) in individual with decreased concentration of AAT (<90mg/dL).

Reference Interval

Components
Reference Interval
Alpha-1-AntitrypsinEffective November 17, 2014
90-200 mg/dL
A1A PhenotypeBy report

CPT Codes

82104; 82103
Collection

LAB4215

Collect

Serum separator tube or plain red.

Specimen Preparation

Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.3 mL)

Storage/Transport Temperature

Refrigerated.

Stability (from collection to initiation)

After separation from cells: Ambient: 1 week; Refrigerated: 3 months; Frozen: 3 months (avoid repeated freeze/thaw cycles)

Notes

Interpret with caution if the patient has been transfused within the previous 21 days.
Ordering

Performed

Sun-Sat

Methodology

Qualitative Isoelectric Focusing/Immunoturbidimetry

Reported

2-4 days

Synonyms

  • A1A Phenotype
  • AAT Phenotype
  • Protease Inhibitor Typing
  • AAT Phenotyping
  • Protease Inhibitor Allo Typing
  • AAT deficiency
  • Antitrypsin
  • A1A Phenotyping
  • AAT Reflex
  • Antitrypsin, Phenotype
  • A1A reflex
  • Alpha 1 Antitrypsin
  • a-1-Antitrypsin, Phenotype
  • A1A genotyping/phenotyping reflex
  • Pi Typing

Additional Technical Information

Ordering Recommendations

Determine specific AAT protein variant(s) in individual with decreased concentration of AAT (<90mg/dL).
Result Interpretation

Reference Interval

Components
Reference Interval
Alpha-1-AntitrypsinEffective November 17, 2014
90-200 mg/dL
A1A PhenotypeBy report

Administrative

CPT Codes

82104; 82103

ALPHA-GALACTOSIDASE - FABRY'S

LAB3731

Collect

One 10 mL yellow (ACD). [Min vol: 4 mL]

Unacceptable Conditions

Green top tube; frozen samples.

Storage/Transport Temperature

Internal: Deliver to lab Sunday - Wednesday
Offsite: 4 mL ACD whole blood Send at refrigerated temperature Mon-Wed only.

Stability (from collection to initiation)

Must be shipped within 48 hours of collection.

 

Ambient: <72 hours

Refrigerated: <72 hours

Frozen: Unacceptable

Remarks

Green top tube not acceptable. Tesing for Fabry's Disease. Testing performed on leukocytes. Samples must be received by reference lab Mon-Fri.

Performed by

Mayo Medical Laboratories

Notes

Effective: 12/1/10

New Method and Reference Range/Reporting units

Performed

Speciemns processed daily Mon-Fri

 

Performed Mon.

Methodology

Fluorometric

Reported

.

Synonyms

  • Galactosidase, Alpha
  • Fabry's Disease
  • Fabry Disease
  • Alpha-galactosidase, WBC
  • Alpha-galactosidase, Leukocytes
  • GLA Deficiency
  • LAB3731

Reference Interval

>= 23.1 nmol/hour/mg protein

Interpretive Data

Results from this assay do not reflect carrier status because of individual variation of alpha-galactosidase enzyme levels.

Deficiency of alpha-galactosidase is diagnostic for Fabry disease

in males.

Carriers are usually within the normal range. If the patient is the mother

of a Fabry patient or the male patient is clearly abnormal, a urine

specimen for a lipid survey is often useful.

Performed by

Mayo Medical Laboratories

CPT Codes

82657

Collection

LAB3731

Collect

One 10 mL yellow (ACD). [Min vol: 4 mL]

Unacceptable Conditions

Green top tube; frozen samples.

Storage/Transport Temperature

Internal: Deliver to lab Sunday - Wednesday
Offsite: 4 mL ACD whole blood Send at refrigerated temperature Mon-Wed only.

Stability (from collection to initiation)

Must be shipped within 48 hours of collection.

 

Ambient: <72 hours

Refrigerated: <72 hours

Frozen: Unacceptable

Remarks

Green top tube not acceptable. Tesing for Fabry's Disease. Testing performed on leukocytes. Samples must be received by reference lab Mon-Fri.

Performed by

Mayo Medical Laboratories

Notes

Effective: 12/1/10

New Method and Reference Range/Reporting units

Ordering

Performed

Speciemns processed daily Mon-Fri

 

Performed Mon.

Methodology

Fluorometric

Reported

.

Synonyms

  • Galactosidase, Alpha
  • Fabry's Disease
  • Fabry Disease
  • Alpha-galactosidase, WBC
  • Alpha-galactosidase, Leukocytes
  • GLA Deficiency
  • LAB3731
Result Interpretation

Reference Interval

>= 23.1 nmol/hour/mg protein

Interpretive Data

Results from this assay do not reflect carrier status because of individual variation of alpha-galactosidase enzyme levels.

Deficiency of alpha-galactosidase is diagnostic for Fabry disease

in males.

Carriers are usually within the normal range. If the patient is the mother

of a Fabry patient or the male patient is clearly abnormal, a urine

specimen for a lipid survey is often useful.

Performed by

Mayo Medical Laboratories

Administrative

CPT Codes

82657

ALTERNATE PATH COMPLEMENT

LAB3731

Collect

One 10 mL yellow (ACD). [Min vol: 4 mL]

Unacceptable Conditions

Green top tube; frozen samples.

Storage/Transport Temperature

Internal: Deliver to lab Sunday - Wednesday
Offsite: 4 mL ACD whole blood Send at refrigerated temperature Mon-Wed only.

Stability (from collection to initiation)

Must be shipped within 48 hours of collection.

 

Ambient: <72 hours

Refrigerated: <72 hours

Frozen: Unacceptable

Remarks

Green top tube not acceptable. Tesing for Fabry's Disease. Testing performed on leukocytes. Samples must be received by reference lab Mon-Fri.

Performed by

Mayo Medical Laboratories

Notes

Effective: 12/1/10

New Method and Reference Range/Reporting units

Performed

Speciemns processed daily Mon-Fri

 

Performed Mon.

Methodology

Fluorometric

Reported

.

Synonyms

  • Galactosidase, Alpha
  • Fabry's Disease
  • Fabry Disease
  • Alpha-galactosidase, WBC
  • Alpha-galactosidase, Leukocytes
  • GLA Deficiency
  • LAB3731

Reference Interval

>= 23.1 nmol/hour/mg protein

Interpretive Data

Results from this assay do not reflect carrier status because of individual variation of alpha-galactosidase enzyme levels.

Deficiency of alpha-galactosidase is diagnostic for Fabry disease

in males.

Carriers are usually within the normal range. If the patient is the mother

of a Fabry patient or the male patient is clearly abnormal, a urine

specimen for a lipid survey is often useful.

Performed by

Mayo Medical Laboratories

CPT Codes

82657

Collection

LAB3731

Collect

One 10 mL yellow (ACD). [Min vol: 4 mL]

Unacceptable Conditions

Green top tube; frozen samples.

Storage/Transport Temperature

Internal: Deliver to lab Sunday - Wednesday
Offsite: 4 mL ACD whole blood Send at refrigerated temperature Mon-Wed only.

Stability (from collection to initiation)

Must be shipped within 48 hours of collection.

 

Ambient: <72 hours

Refrigerated: <72 hours

Frozen: Unacceptable

Remarks

Green top tube not acceptable. Tesing for Fabry's Disease. Testing performed on leukocytes. Samples must be received by reference lab Mon-Fri.

Performed by

Mayo Medical Laboratories

Notes

Effective: 12/1/10

New Method and Reference Range/Reporting units

Ordering

Performed

Speciemns processed daily Mon-Fri

 

Performed Mon.

Methodology

Fluorometric

Reported

.

Synonyms

  • Galactosidase, Alpha
  • Fabry's Disease
  • Fabry Disease
  • Alpha-galactosidase, WBC
  • Alpha-galactosidase, Leukocytes
  • GLA Deficiency
  • LAB3731
Result Interpretation

Reference Interval

>= 23.1 nmol/hour/mg protein

Interpretive Data

Results from this assay do not reflect carrier status because of individual variation of alpha-galactosidase enzyme levels.

Deficiency of alpha-galactosidase is diagnostic for Fabry disease

in males.

Carriers are usually within the normal range. If the patient is the mother

of a Fabry patient or the male patient is clearly abnormal, a urine

specimen for a lipid survey is often useful.

Performed by

Mayo Medical Laboratories

Administrative

CPT Codes

82657

ALUMINUM, SERUM

LAB3103

Collect

3 mL red top .

Unacceptable Conditions

Non-serum samples. Non-frozen samples.

Storage/Transport Temperature

Internal: Deliver to lab immediatley
Offsite: 0.5 mL serum, frozen Separate and ship serum frozen to lab.

Performed by

PCL Clinical Laboratory

Performed

Thu

Methodology

Hemolytic Assay

Reported

Same day

Synonyms

  • COMPLEMENT AH50
  • LAB3103

Reference Interval

New Reference Range (Effective 7/18/09)

77-159 U/mL

Interpretive Data

This assay is used for clinical purposes and
was developed, and its performance characteristics
determined by National Jewish Clinical Reference
Laboratories. It has not been cleared or approved
by the US Food and Drug Administration.

The FDA The FDA has determined that such clearance

or approval is not necessary. This laboratory is certified

under the Clinical Laboratory Improvement Amendments of

1988 [CLIA-88] as qualified to perform high
complexity clinical laboratory testing.

Performed by

PCL Clinical Laboratory

CPT Codes

86162

Collection

LAB3103

Collect

3 mL red top .

Unacceptable Conditions

Non-serum samples. Non-frozen samples.

Storage/Transport Temperature

Internal: Deliver to lab immediatley
Offsite: 0.5 mL serum, frozen Separate and ship serum frozen to lab.

Performed by

PCL Clinical Laboratory

Ordering

Performed

Thu

Methodology

Hemolytic Assay

Reported

Same day

Synonyms

  • COMPLEMENT AH50
  • LAB3103
Result Interpretation

Reference Interval

New Reference Range (Effective 7/18/09)

77-159 U/mL

Interpretive Data

This assay is used for clinical purposes and
was developed, and its performance characteristics
determined by National Jewish Clinical Reference
Laboratories. It has not been cleared or approved
by the US Food and Drug Administration.

The FDA The FDA has determined that such clearance

or approval is not necessary. This laboratory is certified

under the Clinical Laboratory Improvement Amendments of

1988 [CLIA-88] as qualified to perform high
complexity clinical laboratory testing.

Performed by

PCL Clinical Laboratory

Administrative

CPT Codes

86162

AMIKACIN PEAK

LAB3037

AMIKACIN P

Collect

One 5.0 mL gold top with gel (SST), (clot activator serum). Tube must be filled to at least 90% capacity.

Pediatric Collection

0.7 mL in red or gold top microtainer with or without gel.

Unacceptable Conditions

Moderate/severe hemolysis, sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately at ambient temperature.
Offsite: Allow to clot in an upright position for 30 minutes prior to centrifugation. Centrifuge within 60 minutes of collection. Send at 2-8 degrees C.

Stability (from collection to initiation)

Ambient, 6 hours; Refrigerated, 7 days; Frozen (-20 degrees C), Undefined (2 weeks or more).

Remarks

Peak levels of amikacin require blood collection 60 minutes following an I.M. injection or 30 minutes after the end of a 30-60 minute aminoglycoside infusion.

Failure to immediately freeze serum containing additional antibiotics may result in falsely low amikacin levels due to in vitro inactivation

Performed by

PCL Clinical Laboratory - Core

Performed

Upon receipt

Methodology

Turbidimetric immunoassay

Reported

Same day

Synonyms

  • -294
  • LAB3037

Reference Interval

Effective 01/15/2015:

40 - 70 ug/mL

Effective 05/20/2014 through 01/14/2015:

20 - 35 ug/mL

Interpretive Data

Effective 1/15/2015:

For extended interval dosing, peak levels should be 40 - 70 ug/mL.

For Q8h dosing, peak levels should be 10 - 30 ug/mL.

Peaks should be drawn 30 minutes after the end of a 30 - 60 minute aminoglycoside infusion.

Before 1/15/2015:

REFERENCE RANGES
For Q8 dosing, peak levels should be 20 - 25 ug/mL .
For QD dosing, peak levels are not necessary the majority of the time,
but should be greater than 30 ug/mL.

Performed by

PCL Clinical Laboratory - Core

CPT Codes

80150

Collection

LAB3037

AMIKACIN P

Collect

One 5.0 mL gold top with gel (SST), (clot activator serum). Tube must be filled to at least 90% capacity.

Pediatric Collection

0.7 mL in red or gold top microtainer with or without gel.

Unacceptable Conditions

Moderate/severe hemolysis, sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately at ambient temperature.
Offsite: Allow to clot in an upright position for 30 minutes prior to centrifugation. Centrifuge within 60 minutes of collection. Send at 2-8 degrees C.

Stability (from collection to initiation)

Ambient, 6 hours; Refrigerated, 7 days; Frozen (-20 degrees C), Undefined (2 weeks or more).

Remarks

Peak levels of amikacin require blood collection 60 minutes following an I.M. injection or 30 minutes after the end of a 30-60 minute aminoglycoside infusion.

Failure to immediately freeze serum containing additional antibiotics may result in falsely low amikacin levels due to in vitro inactivation

Performed by

PCL Clinical Laboratory - Core

Ordering

Performed

Upon receipt

Methodology

Turbidimetric immunoassay

Reported

Same day

Synonyms

  • -294
  • LAB3037
Result Interpretation

Reference Interval

Effective 01/15/2015:

40 - 70 ug/mL

Effective 05/20/2014 through 01/14/2015:

20 - 35 ug/mL

Interpretive Data

Effective 1/15/2015:

For extended interval dosing, peak levels should be 40 - 70 ug/mL.

For Q8h dosing, peak levels should be 10 - 30 ug/mL.

Peaks should be drawn 30 minutes after the end of a 30 - 60 minute aminoglycoside infusion.

Before 1/15/2015:

REFERENCE RANGES
For Q8 dosing, peak levels should be 20 - 25 ug/mL .
For QD dosing, peak levels are not necessary the majority of the time,
but should be greater than 30 ug/mL.

Performed by

PCL Clinical Laboratory - Core

Administrative

CPT Codes

80150

AMIKACIN RANDOM

LAB3036

AMIKACIN R

Collect

One 5.0 mL gold top with gel (SST), (clot activator serum).

Pediatric Collection

0.7 mL in a red top or gold top microtainer with or without gel.

Unacceptable Conditions

Moderate/severe hemolysis, sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately at ambient temperature.
Offsite: Allow to clot for 30 minutes in an upright position prior to centrifugation. Centrifuge within 60 minutes of collection. Send at 2-8 degrees C.

Stability (from collection to initiation)

Ambient, 6 hours; Refrigerated, 7 days; Frozen (-20 degrees C), Undefined (2 weeks or more).

Remarks

Random levels of amikacin have no reference ranges.

Failure to immediately freeze serum containing additional antibiotics may result in falsely low amikacin levels due to in vitro inactivation.

Performed by

PCL Clinical Laboratory - Core

Performed

Upon receipt

Methodology

Turbidimetric immunoassay

Reported

Daily

Synonyms

  • LAB3036

Interpretive Data

Random levels cannot be easily interpreted. Please contact the Infectious Disease Fellow for
assistance.

Performed by

PCL Clinical Laboratory - Core

CPT Codes

80150

Collection

LAB3036

AMIKACIN R

Collect

One 5.0 mL gold top with gel (SST), (clot activator serum).

Pediatric Collection

0.7 mL in a red top or gold top microtainer with or without gel.

Unacceptable Conditions

Moderate/severe hemolysis, sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately at ambient temperature.
Offsite: Allow to clot for 30 minutes in an upright position prior to centrifugation. Centrifuge within 60 minutes of collection. Send at 2-8 degrees C.

Stability (from collection to initiation)

Ambient, 6 hours; Refrigerated, 7 days; Frozen (-20 degrees C), Undefined (2 weeks or more).

Remarks

Random levels of amikacin have no reference ranges.

Failure to immediately freeze serum containing additional antibiotics may result in falsely low amikacin levels due to in vitro inactivation.

Performed by

PCL Clinical Laboratory - Core

Ordering

Performed

Upon receipt

Methodology

Turbidimetric immunoassay

Reported

Daily

Synonyms

  • LAB3036
Result Interpretation

Interpretive Data

Random levels cannot be easily interpreted. Please contact the Infectious Disease Fellow for
assistance.

Performed by

PCL Clinical Laboratory - Core

Administrative

CPT Codes

80150

AMIKACIN TROUGH

LAB3038

AMIKACIN T

Collect

One 5.0 mL gold top with gel (SST), (clot activator serum). Tube must be filled to at least 90% capacity.

Pediatric Collection

0.7 mL in redtop or gold top microtainer with or without gel.

Unacceptable Conditions

Moderate/severe hemolysis, sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately at ambient temperature.
Offsite: Allow to clot for 30 minutes in an upright position prior to centrifugation. Centrifuge within 60 minutes of collection. Send at 2-8 degrees C.

Stability (from collection to initiation)

Ambient, 6 hours; Refrigerated, 7 days; Frozen (-20 degrees C), Undefined (2 weeks or more).

Remarks

Trough levels of amikacin require blood collection immediately prior to the next dose administered.

Failure to immediately freeze serum containing additional antibiotics may result in falsely low amikacin levels due to in vitro inactivation.

Performed by

PCL Clinical Laboratory - Core

Performed

Upon receipt

Methodology

Turbidimetric immunoassay

Reported

Same day

Synonyms

  • LAB3038

Reference Interval

Effective 05/20/2014:

0 - 8 ug/mL

 

Interpretive Data

REFERENCE RANGES
For Q8 dosing, trough levels should be less than 10 ug/mL.
For QD dosing, trough levels should be less than 5 ug/mL, with the level indicating a potential adjustment in dose if greater than 10 ug/mL.

Performed by

PCL Clinical Laboratory - Core

CPT Codes

80150

Collection

LAB3038

AMIKACIN T

Collect

One 5.0 mL gold top with gel (SST), (clot activator serum). Tube must be filled to at least 90% capacity.

Pediatric Collection

0.7 mL in redtop or gold top microtainer with or without gel.

Unacceptable Conditions

Moderate/severe hemolysis, sample not properly identified; incorrect container; insufficient sample volume.

Storage/Transport Temperature

Internal: Deliver to lab immediately at ambient temperature.
Offsite: Allow to clot for 30 minutes in an upright position prior to centrifugation. Centrifuge within 60 minutes of collection. Send at 2-8 degrees C.

Stability (from collection to initiation)

Ambient, 6 hours; Refrigerated, 7 days; Frozen (-20 degrees C), Undefined (2 weeks or more).

Remarks

Trough levels of amikacin require blood collection immediately prior to the next dose administered.

Failure to immediately freeze serum containing additional antibiotics may result in falsely low amikacin levels due to in vitro inactivation.

Performed by

PCL Clinical Laboratory - Core

Ordering

Performed

Upon receipt

Methodology

Turbidimetric immunoassay

Reported

Same day

Synonyms

  • LAB3038
Result Interpretation

Reference Interval

Effective 05/20/2014:

0 - 8 ug/mL

 

Interpretive Data

REFERENCE RANGES
For Q8 dosing, trough levels should be less than 10 ug/mL.
For QD dosing, trough levels should be less than 5 ug/mL, with the level indicating a potential adjustment in dose if greater than 10 ug/mL.

Performed by

PCL Clinical Laboratory - Core

Administrative

CPT Codes

80150

More Articles...